CCL5 and ovarian carcinoma: It has been also demonstrated that cancer-associated fibroblast (CAF)-derived CCL5 has important roles for cisplatin resistance in ovarian cancer [11], and CD4+ cell-derived CCL5 is involved in the growth and immune escape of gastric carcinoma cells [12].